Actively Recruiting
Ketorolac in Palatoplasty
Led by The University of Texas Health Science Center, Houston · Updated on 2026-02-19
74
Participants Needed
1
Research Sites
288 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively
CONDITIONS
Official Title
Ketorolac in Palatoplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with cleft palate (complete or incomplete), with or without cleft lip, unilateral or bilateral
You will not qualify if you...
- Syndromic cleft palate patients
- Previous palatoplasty surgery
- Major unrepaired cardiac malformation
- History of gastrointestinal complications such as GI bleed or gastric ulceration
- History of kidney disorders
- History of coagulopathy contraindicating NSAID use
- Feeding tube dependency
- Parents refuse to consent to randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
M
Matthew R Greives, MD,MS,FACS
CONTACT
T
Tien Do, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here